A clinicogenetic risk model (m7-FLIPI) prospectively identifies one-half of patients with early disease progression of follicular lymphoma after first-line immunochemotherapy Meeting Abstract
| Authors: | Vindi, J.; Kridel, R.; Staiger, A. M.; Szczepanowski, M.; Horn, H.; Dreyling, M. H.; Rosenwald, A.; Ott, G.; Klapper, W.; Zelenetz, A. D.; Friedberg, J. W.; Ansell, S.; Sehn, L. H.; Connors, J. M.; Gascoyne, R. D.; Weinstock, D. M.; Hiddemann, W.; Unterhalt, M.; Hoster, E.; Weigert, O. |
| Abstract Title: | A clinicogenetic risk model (m7-FLIPI) prospectively identifies one-half of patients with early disease progression of follicular lymphoma after first-line immunochemotherapy |
| Meeting Title: | 57th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 126 |
| Issue: | 23 |
| Meeting Dates: | 2015 Dec 5-8 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2015-12-03 |
| Language: | English |
| ACCESSION: | WOS:000368019001085 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V126.23.333.333 |
| Notes: | Meeting Abstract: 333 -- 57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL -- Source: Wos |
